Log In
BCIQ
Print this Print this
 

Suboxone sublingual film, buprenorphine/naloxone

  Manage Alerts
Collapse Summary General Information
Company Indivior plc
DescriptionSublingual formulation of buprenorphine and naloxone
Molecular Target Mu opioid receptor (MOR) (OPRM1) ; Kappa opioid receptor (KOR) (OPRK1)
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationAddiction
Indication DetailsTreat opioid dependency
Regulatory Designation
PartnerMonoSol Rx LLC

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today